Zota Health Care Limited Stock price

Equities

ZOTA

INE358U01012

Pharmaceuticals

Market Closed - NSE India S.E. 11:43:38 28/02/2024 GMT 5-day change 1st Jan Change
517.8 INR -2.53% Intraday chart for Zota Health Care Limited +3.87% +9.60%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site

Financials

Sales 2022 1.31B 15.84M 1.25B Sales 2023 1.41B 16.99M 1.34B Capitalization 7.09B 85.55M 6.77B
Net income 2022 89M 1.07M 84.96M Net income 2023 -57M -688K -54.41M EV / Sales 2022 5.8 x
Net Debt 2022 126M 1.52M 120M Net Debt 2023 440M 5.31M 420M EV / Sales 2023 5.35 x
P/E ratio 2022
83.1 x
P/E ratio 2023
-123 x
Employees 338
Yield 2022
0.5%
Yield 2023
0.35%
Free-Float 96.37%
More Fundamentals * Assessed data
Dynamic Chart
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Zota Health Care Limited Recommends Final Dividend for the Financial Year 2020-21 CI
Zota Health Care Limited Receives Product Registration Licenses for Ten Products from Turkmenistan CI
Zota Health Care Limited Proposes Declaration of Final Dividend for the Financial Year 2020-21 CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
More news
1 day-2.53%
1 week+3.87%
Current month+2.10%
1 month+5.38%
3 months+25.38%
6 months+21.51%
Current year+9.60%
More quotes
1 week
490.05
Extreme 490.05
555.00
1 month
465.05
Extreme 465.05
555.00
Current year
465.05
Extreme 465.05
555.00
1 year
270.00
Extreme 270
555.00
3 years
137.25
Extreme 137.25
555.00
5 years
121.10
Extreme 121.1
555.00
10 years
103.57
Extreme 103.5714
555.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 15/01/23
Director of Finance/CFO 48 29/09/14
Compliance Officer 33 31/08/15
Members of the board TitleAgeSince
Founder 57 31/12/94
Director/Board Member 49 11/07/00
Director/Board Member 72 11/07/00
More insiders
Date Price Change Volume
28/02/24 517.8 -2.53% 40 442
27/02/24 531.2 -0.79% 57,878
26/02/24 535.5 -2.58% 103,210
23/02/24 549.7 +11.05% 287,506
22/02/24 495 -0.70% 19,399

Delayed Quote NSE India S.E., February 28, 2024 at 11:43 am

More quotes
Zota Health Care Limited is an India-based drug development, manufacturing and marketing company. The Company manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company’s distribution network across India. It has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.
More about the company
  1. Stock
  2. Equities
  3. Stock Zota Health Care Limited - NSE India S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW